Loading
Yanuki
KEYWORD TOPIC
Johnson & Johnson Forecasts Profit Growth Despite Drug Pricing Deal | Johnson & Johnson Stock Falters as Cancer Therapy Gets Warning Label | Johnson & Johnson Forecasts Profit Growth Despite Drug Pricing Deal | Johnson & Johnson Stock Falters as Cancer Therapy Gets Warning Label

Business / Pharmaceuticals

Johnson & Johnson Forecasts Profit Growth Despite Drug Pricing Deal

Johnson & Johnson (JNJ) has released an optimistic forecast for 2026, projecting sales and profit figures that surpass Wall Street expectations. This positive outlook comes despite facing challenges such as a drug pricing agreement with the...

Johnson & Johnson forecasts 2026 profit above Wall Street estimates
Johnson & Johnson Forecasts Profit Growth Despite Drug Pricing Deal Image via CNBC
TOPIC jnj stock

Stocks / Pharmaceuticals

Johnson & Johnson Stock Falters as Cancer Therapy Gets Warning Label

Johnson & Johnson (JNJ) stock is trending lower following an FDA warning label for its Carvykti cancer therapy, even as the company prepares to release its Q3 earnings report. The FDA sanctioned a warning label to be added to Carvykti, a ce...

US FDA adds label warning to J&J's and Legend Biotech's cancer therapy